{"schema_version":"secwatch.filing_event.v1","accession":"0001846253-25-000034","form_type":"8-K","ticker":"OABI","cik":"0001846253","company_name":"OmniAb, Inc.","filed_at":"2025-04-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.117770+00:00","generated_at":"2026-05-23T10:35:58.554954+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"OmniAb appoints two new independent directors; Sarah Boyce resigns","bullets":["Sarah Boyce resigned from Board and all committees effective April 18; no disagreement with company.","Steven C. Crouse and Philip J. Gotwals appointed as Class II directors, terms expiring at 2027 annual meeting.","Crouse (Bio-Techne SVP) and Gotwals (former Novartis BD head) bring life sciences and biopharma expertise.","Each received initial equity grants: RSUs for 40,000 shares and options for 80,000 shares.","Board size increased from six to seven; new directors deemed independent under Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001846253-25-000034","json":"https://secwatch.observer/filing/0001846253-25-000034.json","markdown":"https://secwatch.observer/filing/0001846253-25-000034.md","text":"https://secwatch.observer/filing/0001846253-25-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1846253/000184625325000034/0001846253-25-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1846253/000184625325000034/oabi-20250418.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T10:35:58.554954+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"02e26f138b","claim":"Steven C. Crouse was appointed as Director at OmniAb, Inc..","evidence_excerpt":"the Board appointed Steven C. Crouse and Philip J. Gotwals, Ph.D. to the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1846253/000184625325000034/0001846253-25-000034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"530cdfdeb3","claim":"Philip J. Gotwals was appointed as Director at OmniAb, Inc..","evidence_excerpt":"the Board appointed Steven C. Crouse and Philip J. Gotwals, Ph.D. to the Board","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1846253/000184625325000034/0001846253-25-000034-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}